Lificiguat (YC-1) Liposomes, Formulation FNT8P.2

Mfr.No.	DLL-0016, DLL-0016-A1-10ML
Description	PEGylated liposomes containing HIF-1alpha inhibitor Lificiguat (YC-1). Lificiguat (YC-1) is an inhibitor of Hypoxia-inducible factor-1 alpha (HIF-1 alpha). YC-1 also activates soluble guanylyl cyclase (sGC) in (NO)-independent manner. Lificiguat (YC-1) is insoluble in aqueous media. This product is a pre-formulated liposomal version of Lificiguat which is supplied ready to use in vitro or in vivo. The liposomes are PEGylated for optimal in vivo performance. For preclinical research use only.
Alternative Names	YC-1
Average Size	70-120 nm
Hydration Solution	292 mM sucrose, 0.5% DPBS (1X)
External Solution	FNT8P.2
Signaling pathway	Hypoxia/HIF pathway
Concentration	2.5 mg/mL
Concentration Total Lipid	60 mM
Cas Number	170632-47-0
Types of Liposomes	Drug Loaded Liposomes
Target	cGC, HIF-1alpha

Have you used this product?

Combination SKU	Supplier No.	Volume	Your price	Quantity
BHB19400010-1	DLL-0016-A1-10ML	10mL	$2995		Add to Cart